Raffa Wealth Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$105 Buy
+1
New +$93 ﹤0.01% 1380
2017
Q1
– Sell
-18
Closed -$724 – 569
2016
Q4
$724 Hold
18
– – ﹤0.01% 562
2016
Q3
$652 Hold
18
– – ﹤0.01% 597
2016
Q2
$522 Hold
18
– – ﹤0.01% 669
2016
Q1
$630 Hold
18
– – ﹤0.01% 586
2015
Q4
$580 Hold
18
– – ﹤0.01% 619
2015
Q3
$582 Hold
18
– – ﹤0.01% 596
2015
Q2
$744 Hold
18
– – ﹤0.01% 488
2015
Q1
$809 Hold
18
– – ﹤0.01% 463
2014
Q4
$674 Hold
18
– – ﹤0.01% 510
2014
Q3
$629 Buy
+18
New +$642 ﹤0.01% 493
2014
Q1
– Sell
-18
Closed -$674 – 459
2013
Q4
$674 Buy
+18
New +$741 ﹤0.01% 510

Other funds holding HAE

Raffa Wealth Management's HAE Position: Q3 2026 in Review

Raffa Wealth Management opened a new position in Haemonetics (HAE) in Q3 2026: 1 share worth $105. The stake represents ﹤0.01% of the portfolio and ranks #1380 among its holdings. This is a return to the name: Raffa Wealth Management previously reported a position in HAE as recently as Q4 2016.

Raffa Wealth Management first reported a position in HAE in Q4 2013 and has held it in 12 quarters since. The position peaked at $809 in Q1 2015. 361 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Raffa Wealth Management held 1 share of Haemonetics worth $105 as of Q3 2026.
  • Haemonetics was a new Raffa Wealth Management position in Q3 2026.
  • Haemonetics made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1380 holding.
  • Raffa Wealth Management first reported a position in Haemonetics in Q4 2013 and has held it in 12 quarters since.
  • Raffa Wealth Management's Haemonetics position peaked at $809 in Q1 2015.
  • 361 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.